Boz, CavitÖzakbaş, SerkanTerzi, MuratTürkoğlu, RecaiAkman, GülşenEfendi, HüsnüAkçalı, AylinTuncer, AlaettinYüceyar, NurSoysal, AysunKöseoğlu, M.Balcı, Belgin PetekSevim, SerhanAltıntaş, AyşeÇilingir, VedatDemirkıran, MeltemKızılay, FerahAltunrende, Burcu2023-08-082023-08-082017-10Boz, C. vd. (2017). ''Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis''. Multiple Sclerosis Journal, 23(Supplement 3), 327-328.1352-45851477-0970https://journals.sagepub.com/toc/msja/23/3_supplhttp://hdl.handle.net/11452/33415Bu çalışma, 25-28, Ekim 2017 tarihlerinde Paris[Fransa]’ de düzenlenen 7. Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessNeurosciences & neurologyReal world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosisMeeting Abstract00041373020206832732823Suplement 3Clinical neurologyNeurosciences